Hélène Donnadieu‐Rigole
Biographic Data
| ID | 7180309 |
|---|---|
| NAME | Hélène Donnadieu‐Rigole |
| GIVEN NAMES | Hélène |
| FAMILY NAME | Donnadieu‐Rigole |
| SIGNATURE | RIGOLE H D |
| AFFILIATIONS | Centre Hospitalier Universitaire de Montpellier |
| ORCID | 0000-0001-8398-812X |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Management of Pregabalin Use Disorder
Pregabalin is indicated for the treatment of partial epilepsy, generalized anxiety disorder, and neuropathic pain. The first reports on pregabalin use disorder have been published in Europe in 2010 and notified to the French Addictovigilance Network (FAN) in 2011. The management of pregabalin use disorder is challenging due to the risks associated with the abrupt withdrawal and lack of guidelines. In this retrospective observational study, the ma…
High Prevalence of Misuse of Prescribed Opioid Analgesics in Patients with Chronic Non-Cancer Pain
Opioid analgesic misuse by patients with chronic non-cancer pain is increasing in Western countries. To determine the extent of opioid misuse by patients with chronic non-cancer pain followed at a French pain management clinic. A questionnaire on pain (severity, causes and management) and opioid misuse (based on the 11 DSM-V criteria for substance abuse disorders) was administered by a health professional to patients during a short hospitalizatio…
No prominent works on this page.
High Prevalence of Misuse of Prescribed Opioid Analgesics in Patients with Chronic Non-Cancer Pain
Opioid analgesic misuse by patients with chronic non-cancer pain is increasing in Western countries. To determine the extent of opioid misuse by patients with chronic non-cancer pain followed at a French pain management clinic. A questionnaire on pain (severity, causes and management) and opioid misuse (based on the 11 DSM-V criteria for substance abuse disorders) was administered by a health professional to patients during a short hospitalizatio…
Management of Pregabalin Use Disorder
Pregabalin is indicated for the treatment of partial epilepsy, generalized anxiety disorder, and neuropathic pain. The first reports on pregabalin use disorder have been published in Europe in 2010 and notified to the French Addictovigilance Network (FAN) in 2011. The management of pregabalin use disorder is challenging due to the risks associated with the abrupt withdrawal and lack of guidelines. In this retrospective observational study, the ma…
Medicine (2 works) · Opioid Use Disorder Treatment (2 works) · Psychiatry (2 works) · Addiction (1 works) · Analgesic (1 works) · Anxiety (1 works) · Cancer (1 works) · Cancer pain (1 works) · Chronic pain (1 works) · Fibromyalgia (1 works)